The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
MicroRNA-223 Suppresses IL-1β and TNF-α Production in Gouty Inflammation by Targeting the NLRP3 Inflammasome
Abstract
Introduction: MicroRNA-223 (MiR-223) serves as an important regulator of inflammatory and immune responses and is implicated in several auto-inflammatory disorders. Here, we measured miR-223 expression in acute and intercritical gout patients, after which we used RAW264.7 macrophages transfected with a miR-223 mimic/inhibitor to determine the function of miR-223 in monosodium urate (MSU)-induced gouty inflammation. Methods and Results: MiR-223 was detected among 122 acute gout patients (AG), 118 intercritical gout patients (IG), and 125 healthy subjects (HC). RAW264.7 macrophages were cultured and treated with MSU. Over-expression or under-expression of miR-223 was inducted in RAW264.7 macrophages to investigate the function of miR-223. Real-time quantitative PCR, ELISA and western blotting were used to determine the expression levels of miR-223, cytokines and the NLRP3 inflammasome (NLRP3, ASC, and caspase-1). MiR-223 expression was significantly decreased in the AG group in comparison with the IG and HC groups (p < 0.001, respectively). Up-regulated expression of miR-223 was observed after acute gout remission in comparison with that observed during gout flares in 30 paired cases (p < 0.001). The abundance of the NLRP3 inflammasome and cytokines was significantly increased after RAW264.7 macrophages were treated with MSU (p < 0.01, respectively), while that of miR-223 was significantly reduced (p < 0.01). Up-regulation of miR-223 decreased the concentrations of IL-1β and TNF-α, as well as the NLRP3 inflammasome expression (p < 0.01, respectively), while IL-37 and TGF-β1 levels were unchanged (p > 0.05, respectively). Under-expression of miR-223 increased the concentrations of IL-1β and TNF-α, as well as NLRP3 inflammasome expression (p < 0.01, respectively), while IL-37 and TGF-β1 levels were not influenced (p > 0.05, respectively). Conclusion: These findings suggest that miR-223 provides negative feedback regulation of the development of gouty inflammation by suppressing production of IL-1β and TNF-α, but not by regulating IL-37 and TGF-β1. Moreover, miR-223 regulates cytokine production by targeting the NLRP3 inflammasome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within macrophages, miR-223 modulates the expression of IL-1β by targeting Nlrp3 [66].”
From miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1 (2024) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Preliminary criteria for the classification of the acute arthritis of primary gout
Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., Mccarty, D. J., & Yü, T. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200320 · Cited by 1,432
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Dehlin, M., Jacobsson, L., & Roddy, E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0441-1 · Cited by 1,370
Global epidemiology of gout: prevalence, incidence and risk factors
Kuo, C.-F., Grainge, M. J., Zhang, W., & Doherty, M. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.91 · Cited by 1,179
Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00346-9 · Cited by 1,087
Neogi, T., Jansen, T. L. T. A., Dalbeth, N., Fransen, J., Schumacher, H. R., Berendsen, D., Brown, M., Choi, H., Edwards, N. L., Janssens, H. J. E. M., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39254 · Cited by 669
Inflammation in gout: mechanisms and therapeutic targets
So, A. K., & Martinon, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.155 · Cited by 608
NLRP3 inflammasome activity is negatively controlled by miR-223
Bauernfeind, F., Rieger, A., Schildberg, F. A., Knolle, P. A., Schmid-Burgk, J. L., & Hornung, V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201516 · Cited by 544
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Haneklaus, M., Gerlic, M., Kurowska-Stolarska, M., Rainey, A.-A., Pich, D., McInnes, I. B., Hammerschmidt, W., O’Neill, L. A. J., & Masters, S. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200312 · Cited by 411
Costa, A., Toschi, A., Murfuni, I., Pelosi, L., Sica, G., Adamo, S., & Scicchitano, B. M. (2014) · BioMed Research International · doi:10.1155/2014/235426 · Cited by 247
MicroRNAs in epilepsy: pathophysiology and clinical utility
Henshall, D. C., Hamer, H. M., Pasterkamp, R. J., Goldstein, D. B., Kjems, J., Prehn, J. H. M., Schorge, S., Lamottke, K., & Rosenow, F. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30246-0 · Cited by 246
Renaudin, F., Orliaguet, L., Castelli, F., Fenaille, F., Prignon, A., Alzaid, F., Combes, C., Delvaux, A., Adimy, Y., Cohen-Solal, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217342 · Cited by 176
MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis
Jin, H. M., Kim, T., Choi, J., Kim, M., Cho, Y., Nam, K. I., Kee, S., Moon, J. B., Choi, S., Park, D.-J., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4531 · Cited by 96
MiR-223-3p inhibits rTp17-induced inflammasome activation and pyroptosis by targeting NLRP3
Long, F., Kou, C., Li, K., Wu, J., & Wang, Q. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16061 · Cited by 87 · cited 2×
“Recently, the role of miRs in negatively regulating inflammation in autoimmune diseases and inflammation disorders has received increasing attention (Henshall et al., 2016; Long et al., 2020).”
BackgroundZhang, Q., Qing, Y., Yin, C., Zhou, L., Liu, X., Mi, Q., & Zhou, J. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1546-7 · Cited by 81
Self-citationLioté, F., Prudhommeaux, F., Schiltz, C., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390718 · Cited by 80
Mechanisms of Spontaneous Resolution of Acute Gouty Inflammation
Steiger, S., & Harper, J. L. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0392-5 · Cited by 74
MicroRNA-488 and -920 regulate the production of proinflammatory cytokines in acute gouty arthritis
Zhou, W., Wang, Y., Wu, R., He, Y., Su, Q., & Shi, G. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1418-6 · Cited by 74
Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals
Dalbeth, N., Pool, B., Shaw, O. M., Harper, J. L., Tan, P., Franklin, C., House, M. E., Cornish, J., & Naot, D. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205409 · Cited by 63
Qing, Y., Zhang, Q., Zhou, J., & Jiang, L. (2013) · Rheumatology International · doi:10.1007/s00296-013-2856-3 · Cited by 61
Self-citationZeng, M., Dang, W., Chen, B., Qing, Y., Xie, W., Zhao, M., & Zhou, J. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-3109-5 · Cited by 53
Self-citationGout in China, 1990–2017: the Global Burden of Disease Study 2017
Tang, Y., Zhang, L., Zhu, S., Pan, J., Zhou, S. H., He, T., & Li, Q. (2021) · Public Health · doi:10.1016/j.puhe.2020.06.029 · Cited by 48
Self-citationTherapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases
García‐Martinez, I., Shaker, M. E., & Mehal, W. Z. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6383 · Cited by 47
Ma, T., Liu, X., Cen, Z., Xin, C., Guo, M., Zou, C., Song, W., Xie, R., Wang, K., Zhou, H., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1528-9 · Cited by 47
Wang, D., Sun, S., Xue, Y., Qiu, J., Ye, T., Zhang, R., Song, B., He, W., Zhang, Y., & Jiang, W. (2020) · International Endodontic Journal · doi:10.1111/iej.13413 · Cited by 47
MicroRNA-223 targets NLRP3 to relieve inflammation and alleviate spinal cord injury
Zhang, M., Wang, L., Huang, S., & He, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117796 · Cited by 43
Myeloid-Derived microRNAs, miR-223, miR27a, and miR-652, Are Dominant Players in Myeloid Regulation
Gilicze, A., Wiener, Z., Tóth, S., Buzás, E. I., Pállinger, É., Falcone, F. H., & Falus, A. (2014) · BioMed Research International · doi:10.1155/2014/870267 · Cited by 42
Li, G., Zhang, H., Ma, H., Qu, S., Xing, Q., & Wang, G. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14028 · Cited by 32
Cited by
Ou, Z., Cheng, Y., Ma, H., Chen, K., Lin, Q., Chen, J., Guo, R., Huang, Z., Cheng, Q., Alaeiilkhchi, N., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05480-5 · Cited by 23
Metadata
- Authors
- Zhang, Q.-B., Zhu, D., Dai, F., Huang, Y.-Q., Zheng, J.-X., Tang, Y.-P., Dong, Z.-R., Liao, X., & Qing, Y.-F.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-04-16
- Volume
- 12
- ISSN
- 1663-9812
- PMC
- PMC8085756
- Cited by
- 45
- References
- 30
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.